Citations

Showing 10 of 107868 citations.

Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma
Zou, Hongzhi , Kreinest, Pamela, Childs, April C., Belmonte, Leandra S., LeGrand, Shauna N., Wu, Kevin J. , Luxon, Bruce A. , Sinha, Mala, Parker, Alexander S. , Sun, L-Z, Ahlquist, David A. , Wood, Christopher G. , Copland, John A. , Gumz, Michelle L.

Mayo Clinic

Clinical Cancer Research | August 15, 2007 | Volume: 13 | Issue: 16 | Pages: 4740-4749

10.1158/1078-0432.ccr-07-0143 | PMID 17699851 Get It

Abstract Purpose: Incidence and mortality rates for renal cell carcinoma (RCC) have been rising for decades. Unfortunately, the molecular events that support RCC carcinogenesis remain poorly understood. In an effort to gain a better understanding of signaling events in clear cell RCC (cRCC), we investigated the antitumor activity of secreted frizzled-related protein 1 (sFRP1), a negative regulator of Wnt signaling. Experimental Design: Genomic profiling of cRCC tumors and patient-matched normal tissues was done and confirmed using quantitative PCR and immunohistochemistry. Methylation-specific PCR was done on patient samples to evaluate the mechanism responsible for sFRP1 loss. sFRP1 expression was restored in cRCC cells and the effects on tumor phenotype were characterized. Results: Genomic profiling, quantitative PCR, and immunohistochemistry indicated that loss of sFRP1 occurred in cRCC and papillary RCC patient tissues. Twelve Wnt-regulated genes were up-regulated in cRCC tissues, including c-myc and cyclin D1, potentiators of cell proliferation and survival. Methylation of the sFRP1 gene was one mechanism identified for attenuation of sFRP1 mRNA. Stable reexpression of sFRP1 in cRCC cells resulted in decreased expression of Wnt target genes, decreased growth in cell culture, inhibition of anchorage-independent growth, and decreased tumor growth in athymic nude mice. Conclusions: To our knowledge, this is the first report to show that stable restoration of sFRP1 expression in cRCC cells attenuates the cRCC tumor phenotype. Our data support a role for sFRP1 as a tumor suppressor in cRCC and that perhaps loss of sFRP1 is an early, aberrant molecular event in renal cell carcinogenesis.
Involvement of RNA Helicases p68 and p72 in Colon Cancer
Shin, Sook , Rossow, Kari L., Grande, Joseph P. , Janknecht, Ralf

Mayo Clinic

Cancer Research | August 15, 2007 | Volume: 67 | Issue: 16 | Pages: 7572-7578

10.1158/0008-5472.can-06-4652 | PMID 17699760 Get It

Abstract The homologous proteins p68 and p72 are members of the DEAD box family of RNA helicases. Here, we show that expression of both of these helicases strongly increases during the polyp→adenoma→adenocarcinoma transition in the colon. Furthermore, p68 and p72 form complexes with β-catenin and promote the ability of β-catenin to activate gene transcription. Conversely, simultaneous knockdown of p68 and p72 leads to reduced expression of the β-catenin–regulated genes, c-Myc, cyclin D1, c-jun, and fra-1, all of which are proto-oncogenes. Moreover, transcription of the cell cycle inhibitor p21WAF1/CIP1, whose expression is suppressed by c-Myc, is enhanced on p68/p72 knockdown. Thus, p68/p72 may contribute to colon cancer formation by directly up-regulating proto-oncogenes and indirectly by down-regulating the growth suppressor p21WAF1/CIP1. Accordingly, knockdown of p68 and p72 in colon cancer cells inhibits their proliferation and diminishes their ability to form tumors in vivo. Altogether, these results suggest that p68/p72 overexpression is not only a potential marker of colon cancer but is also causally linked to this disease. Therefore, p68 and p72 may be novel targets in the combat against colon cancer. [Cancer Res 2007;67(16):7572–8]
Editorial Comment
Petrou, Steven

Mayo Clinic

Journal of Urology | August 15, 2007 | Volume: 178 | Issue: 4 | Pages: 1332-1332

10.1016/j.juro.2007.05.260 Get It

Does Preoperative Topical Antimicrobial Scrub Reduce Positive Surgical Site Culture Rates in Men Undergoing Artificial Urinary Sphincter Placement?
Magera, James S., Inman, Brant A. , Elliott, Daniel S. , Inman, Brant A

Mayo Clinic

Journal of Urology | August 15, 2007 | Volume: 178 | Issue: 4 | Pages: 1328-1332

10.1016/j.juro.2007.05.146 | PMID 17698144 Get It

Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression
Willhauck, Michael J., Samani, Bibi-Rana Sharif, Gildehaus, Franz‐Josef, Senekowitsch–Schmidtke, Reingard, Stark, Hans‐Jürgen, Göke, Burkhard, Spitzweg, Christine , Samani, Bibi Rana Sharif, Wolf, Ingo , Morris, John C.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | August 15, 2007 | Volume: 92 | Issue: 11 | Pages: 4451-4458

10.1210/jc.2007-0402 | PMID 17698909 Get It

Abstract Context: We reported recently the induction of iodide accumulation in prostate cancer cells (LNCaP) by prostate-specific antigen promoter-directed sodium iodide symporter (NIS) expression that allowed a significant therapeutic effect of 131iodine (131I). These data demonstrated the potential of the NIS gene as a novel therapeutic gene, although in some extrathyroidal tumors, therapeutic efficacy may be limited by rapid iodide efflux due to a lack of iodide organification. Objective: In the current study, we therefore studied the potential of 188rhenium (188Re), as an alternative radionuclide, also transported by NIS, with a shorter half-life and higher energy β-particles than 131I. Results: NIS-transfected LNCaP cells (NP-1) concentrated 8% of the total applied activity of 188Re as compared with 16% of 125I, which was sufficient for a therapeutic effect in an in vitro clonogenic assay. γ-Camera imaging of NP-1 cell xenografts in nude mice revealed accumulation of 8–16% injected dose (ID)/g 188Re (biological half-life 12.9 h), which resulted in a 4.7-fold increased tumor absorbed dose (450 mGy/MBq) for 188Re as compared with 131I. After application of 55.5 MBq 131I or 188Re, smaller tumors showed a similar average volume reduction of 86%, whereas in larger tumors volume reduction was significantly increased from 73% after 131I treatment to 85% after application of 188Re. Conclusion: Although in smaller prostate cancer xenografts both radionuclides seemed to be equally effective after prostate-specific antigen promoter-mediated NIS gene delivery, a superior therapeutic effect has been demonstrated for 188Re in larger tumors.
Predicting the Development of Cushing's Syndrome in Medullary Thyroid Cancer: Utility of Proopiomelanocortin Messenger Ribonucleic Acid In Situ Hybridization
Sheikh‐Ali, Mae, Krishna, Murli, Lloyd, Ricardo V., Smallridge, Robert C.

Mayo Clinic

Thyroid | August 14, 2007 | Volume: 17 | Issue: 7 | Pages: 631-634

10.1089/thy.2007.0062 | PMID 17696832 Get It

Cell Biology of Pathologic Renal Calcification: Contribution of Crystal Transcytosis, Cell-Mediated Calcification, and Nanoparticles
Farell, Gerard, Yu, Shihui , Harrington, Sean C., Fitzpatrick, Lorraine A. , Rzewuska, Ewa, Miller, Virginia M. , Kumar, Vivek , Lieske, John C.

Mayo Clinic

Journal of Investigative Medicine | August 13, 2007 | Volume: 54 | Issue: 7 | Pages: 412-424

10.2310/6650.2006.06021 | PMID 17169263 Get It

Introduction The earliest lesion in the kidneys of idiopathic calcium oxalate stone formers is deposition of calcium phosphate in the interstitium, termed a Randall's plaque. Yet the cellular and molecular factors leading to their formation are unknown. Methods The influence of urinary proteins on adhesion of preformed calcium oxalate crystals to rat continuous inner medullary collecting duct (cIMCD) cells was studied in vitro, and cIMCD cells were also exposed to calcifying media containing β-glycerophosphate for up to 28 days. Renal tissue was obtained from a stone-forming and non-stone-forming individual at the time of nephrectomy. These nanoparticles, isolated from renal stones obtained at the time of surgical resection, were analyzed and propagated in standard cell culture medium. Results Urinary proteins influence crystal adhesion to renal epithelial cells, and this activity is abnormal in the urine of stone-forming patients. cIMCD cells assumed an osteoblastic phenotype when exposed to the calcifying medium, expressing two bone matrix proteins (osteopontin and bone sialoprotein) that were also identified in the kidney of the stone-forming patient and associated with crystal deposition. Nanoparticles were propagated from the majority of renal stones. Isolates were susceptible to selected metabolic inhibitors and antibiotics and contained conserved bacterial proteins and deoxyribonucleic acid (DNA). Conclusions These results suggest new paradigms for Randall's plaque formation and idiopathic calcium oxalate stone disease. It seems unlikely that these events are driven solely by physical chemistry; rather, they are critically influenced by specific proteins and cellular responses, and understanding these events will provide clues toward novel therapeutic targets.
Search for Microbial Signatures within Human and Microbial Calcifications Using Soft X-Ray Spectromicroscopy
Benzerara, Karim , Miller, Virginia M. , Barell, Gerard, Miot, Jennyfer, Brown, Gordon E. , Kumar, Vivek , Lieske, John C.

Mayo Clinic

Journal of Investigative Medicine | August 13, 2007 | Volume: 54 | Issue: 7 | Pages: 367-379

10.2310/6650.2006.06016 | PMID 17169258 Get It

Background The origin of advanced arterial and renal calcification remains poorly understood. Self-replicating, calcifying entities have been detected and isolated from calcified human tissues, including blood vessels and kidney stones, and are referred to as nanobacteria. However, the microbiologic nature of putative nanobacteria continues to be debated, in part because of the difficulty in discriminating biomineralized microbes from minerals nucleated on anything else (eg, macromolecules, cell membranes). To address this controversy, the use of techniques capable of characterizing the organic and mineral content of these self-replicated structures at the submicrometer scale would be beneficial. Methods Calcifying gram-negative bacteria ( Caulobacter crescentus, Ramlibacter tataouinensis) used as references and self-replicating calcified nanoparticles cultured from human samples of calcified aneurysms were examined using a scanning transmission x-ray microscope (STXM) at the Advanced Light Source at Lawrence Berkeley National Laboratory. This microscope uses a monochromated and focused synchrotron x-ray beam (80-2,200 eV) to yield microscopic and spectroscopic information on both organic compounds and minerals at the 25 nm scale. Results High-spatial and energy resolution near-edge x-ray absorption fine structure (NEXAFS) spectra indicative of elemental speciation acquired at the C K-edge, N K-edge, and Ca L 2,3 -edge on a single-cell scale from calcified C. crescentus and R. tataouinensis displayed unique spectral signatures different from that of nonbiologic hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ). Further, preliminary NEXAFS measurements of calcium, carbon, and nitrogen functional groups of cultured calcified nanoparticles from humans revealed evidence of organics, likely peptides or proteins, specifically associated with hydroxyapatite minerals. Conclusion Using NEXAFS at the 25 nm spatial scale, it is possible to define a biochemical signature for cultured calcified bacteria, including proteins, polysaccharides, nucleic acids, and hydroxyapatite. These preliminary studies suggest that nanoparticles isolated from human samples share spectroscopic characteristics with calcified proteins.
Introduction to Pathologic Calcification: Crystallization, Infection, or Cellular Transdifferentiation
Miller, Virginia M. , Salahudeen, Abdulla K., Lieske, John C.

Mayo Clinic

Journal of Investigative Medicine | August 13, 2007 | Volume: 54 | Issue: 7 | Pages: 365-366

10.2310/6650.2006.06015 | PMID 17169257 Get It

Natriuretic Peptides: Novel Therapeutic Targets in Heart Failure
Cataliotti, Alessandro , Burnett, John C.

Mayo Clinic

Journal of Investigative Medicine | August 13, 2007 | Volume: 53 | Issue: 7 | Pages: 378-384

10.2310/6650.2005.53711 | PMID 16297366 Get It

Since the discovery of the cardiac hormone atrial natriuretic peptide by de Bold and colleagues in 1981, the field of natriuretic peptides has significantly advanced with translation of new knowledge to the clinical practice of heart failure. This new knowledge builds on the importance of cardiorenal mechanisms that contribute to optimal cardiovascular regulation. Recent investigations by our group and others have also established the direct myocardial actions of the natriuretic peptides, broadening their therapeutic potential beyond renal mechanisms. Indeed, a potential therapeutic target is cardiac remodeling and fibrosis based on the unique cardiorenal and humoral protective properties that natriuretic peptides possess. We review new insights into the natriuretic peptide system and specifically focus on the possible role of natriuretic peptides as a new therapeutic strategy to limit cardiac remodeling and fibrosis to delay worsening of cardiac function and the progression of heart failure.